Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
86.3M
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
39.6M
-
Shares change
-
-563K
-
Total reported value, excl. options
-
$67.8M
-
Value change
-
-$1.21M
-
Put/Call ratio
-
1.17
-
Number of buys
-
29
-
Number of sells
-
-20
-
Price
-
$1.71
Significant Holders of Century Therapeutics, Inc. - Common Stock, $0.0001 par value per share (IPSC) as of Q3 2024
72 filings reported holding IPSC - Century Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q3 2024.
Century Therapeutics, Inc. - Common Stock, $0.0001 par value per share (IPSC) has 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39.6M shares
of 86.3M outstanding shares and own 45.94% of the company stock.
Largest 10 shareholders include Bain Capital Life Sciences Investors, LLC (5.41M shares), VR Adviser, LLC (5.39M shares), Boxer Capital, LLC (3.9M shares), Casdin Capital, LLC (3.21M shares), BlackRock, Inc. (2.99M shares), FMR LLC (2.52M shares), VANGUARD GROUP INC (2.48M shares), MORGAN STANLEY (2.27M shares), DAFNA Capital Management LLC (1.7M shares), and ADAGE CAPITAL PARTNERS GP, L.L.C. (1.32M shares).
This table shows the top 66 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.